Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DVA

DaVita Inc

Oct 31 • 04:00PM ET

119.02

+0.27 0.23 %

Healthcare • Medical Care Facilities • USA • NYSE

Peers: FMS DNLI OMCL MMSI BAX AMED DXCM UHS

| Held by: VTI RSP VOO VB VBR IVV SPY IWP XLV OMAH

Scroll to Statements

Index	S&P 500	P/E	12.26	EPS (ttm)	9.71	Insider Own	4.86%	Shs Outstand	70.98M	Perf Week	-7.87%
Market Cap	8.40B	Forward P/E	9.39	EPS next Y	12.68	Insider Trans	-49.67%	Shs Float	67.17M	Perf Month	-9.90%
Enterprise Value	22.27B	PEG	0.83	EPS next Q	3.10	Inst Own	96.45%	Short Float	9.70%	Perf Quarter	-14.69%
Income	771.91M	P/S	0.63	EPS this Y	10.19%	Inst Trans	-0.83%	Short Ratio	8.00	Perf Half Y	-15.67%
Sales	13.32B	P/B	-	EPS next Y	18.86%	ROA	4.40%	Short Interest	6.52M	Perf YTD	-20.41%
Book/sh	-8.06	P/C	10.17	EPS next 5Y	14.77%	ROE	635.30%	52W High	179.60 -33.73%	Perf Year	-24.82%
Cash/sh	11.70	P/FCF	6.49	EPS past 3/5Y	6.43% 15.27%	ROIC	6.59%	52W Low	117.73 1.10%	Perf 3Y	19.85%
Dividend Est.	-	EV/EBITDA	8.43	Sales past 3/5Y	3.32% 2.39%	Gross Margin	26.70%	Volatility	3.84% 2.48%	Perf 5Y	32.67%
Dividend TTM	-	EV/Sales	1.67	EPS Y/Y TTM	4.37%	Oper. Margin	14.57%	ATR (14)	3.36	Perf 10Y	56.73%
Dividend Ex-Date	-	Quick Ratio	1.32	Sales Y/Y TTM	5.14%	Profit Margin	5.80%	RSI (14)	30.40	Recom	2.92
Dividend Gr. 3/5Y	- -	Current Ratio	1.36	EPS Q/Q	-18.56%	SMA20	-5.96%	Beta	1.13	Target Price	147.00
Payout	0.00%	Debt/Eq	-	Sales Q/Q	4.80%	SMA50	-9.05%	Rel Volume	1.69	Prev Close	118.75
Employees	76000	LT Debt/Eq	-	Earnings	Oct 29 AMC	SMA200	-16.56%	Avg Volume	814.65K	Price	119.02
IPO	Oct 31, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-22.08% -0.43%	Trades		Volume	1,373,165	Change	0.23%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-24	Initiated	Barclays	Equal Weight	$133
Aug-07-23	Upgrade	UBS	Neutral → Buy	$100 → $142
Nov-01-22	Downgrade	Deutsche Bank	Buy → Hold	$97 → $72
Oct-31-22	Downgrade	UBS	Buy → Neutral	$117 → $74
Aug-19-22	Resumed	UBS	Buy	$106 → $117
Jun-21-22	Reiterated	BofA Securities	Underperform	$110 → $90
Sep-10-21	Initiated	Cowen	Market Perform	$145
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight	$135 → $146
Mar-26-21	Downgrade	BofA Securities	Neutral → Underperform	$127 → $118
Jan-05-21	Downgrade	BofA Securities	Buy → Neutral	$127
Jan-24-20	Upgrade	Goldman	Neutral → Buy	$72 → $97
Nov-07-19	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-25-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-11-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-26-19	Downgrade	Robert W. Baird	Outperform → Neutral	$70 → $65
Jan-08-19	Upgrade	UBS	Sell → Neutral
Jan-03-19	Initiated	Deutsche Bank	Buy	$60
Dec-14-18	Initiated	Barclays	Overweight
Nov-28-18	Upgrade	Raymond James	Mkt Perform → Outperform
Nov-16-18	Initiated	UBS	Sell	$64

Show Previous Ratings

Oct-30-25 07:39PM	Analyst Report: DaVita Inc. (Morningstar Research) -6.17%
01:59PM	DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
01:35AM	DVA Q3 2025 Deep Dive: Lower Volumes and Margin Compression Shape Outlook Amid Industry Uncertainty (StockStory)
Oct-29-25 05:25PM	DaVita (NYSE:DVA) Reports Q3 In Line With Expectations (StockStory)
05:25PM	DaVita HealthCare (DVA) Q3 Earnings Lag Estimates (Zacks)
04:05PM	Loading…
04:05PM	DaVita Inc. 3rd Quarter 2025 Results (PR Newswire)
Oct-28-25 11:27AM	Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating (Insider Monkey)
11:27AM	Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? (Zacks)
Oct-27-25 11:07PM	DaVita (DVA) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-26-25 04:23PM	3 Healthcare Stocks That Are Screaming Deals Right Now (Motley Fool)
Oct-20-25 06:00PM	DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider (Zacks)
08:00AM	DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives (PR Newswire)
Oct-17-25 09:06AM	Earnings Preview: What to Expect From DaVita's Report (Barchart)
Oct-14-25 06:15PM	DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note (Zacks)
Oct-13-25 02:00PM	DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call (PR Newswire)
01:01PM	Loading…
Oct-12-25 01:01PM	Business People: Marine technician Dan Derfler celebrates 50 years at MarineMax Nisswa (Pioneer Press, St. Paul, Minn.)
Oct-08-25 11:31PM	Outpatient & Specialty Care Stocks Q2 Highlights: DaVita (NYSE:DVA) (StockStory)
06:00PM	DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Oct-06-25 06:15PM	DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Oct-03-25 09:45AM	DaVita HealthCare (DVA) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Oct-02-25 09:40AM	Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term (Zacks)
Sep-30-25 06:15PM	DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts (Zacks)
Sep-25-25 10:21AM	Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant (Zacks)
Sep-24-25 01:11PM	4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends (Zacks)
Sep-23-25 06:00PM	DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know (Zacks)
09:56AM	Is DaVita Stock Underperforming the Nasdaq? (Barchart)
Sep-22-25 09:40AM	Should Value Investors Buy DaVita (DVA) Stock? (Zacks)
Sep-17-25 06:00PM	DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
09:45AM	Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term (Zacks)
Sep-16-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:45AM	Loading…
Sep-13-25 09:45AM	Jim Cramer Highlights DaVita's Massive Buybacks Yet Stays Cautious (Insider Monkey)
Sep-10-25 06:00PM	Why DaVita (DVA) Stock Is Falling Today (StockStory)
06:00PM	DaVita HealthCare (DVA) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
12:05AM	3 Reasons DVA is Risky and 1 Stock to Buy Instead (StockStory)
Sep-02-25 04:26PM	Should Value Investors Buy DaVita (DVA) Stock? (Zacks)
Sep-01-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-29-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
12:33AM	DaVita (DVA) Confirms Ransomware Attack Impacted 2.7M People (Insider Monkey)
Aug-27-25 09:53AM	DaVita Inc. (DVA): A Bull Case Theory (Insider Monkey)
08:00AM	DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care (PR Newswire)
Aug-22-25 06:12AM	Ransomware attack on DaVita exposes data from 2.7M (Healthcare Dive)
Aug-15-25 10:10AM	Cardinal Health to Acquire Solaris Health for Urology Expansion (Zacks)
06:10AM	2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid (Motley Fool)
Aug-14-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Aug-13-25 12:12AM	DaVita's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Aug-12-25 11:51PM	DVA Q2 Deep Dive: Cyber Incident Drives Volume Headwinds as Cost Controls Support Outlook (StockStory)
09:40AM	Here's Why DaVita HealthCare (DVA) is a Strong Value Stock (Zacks)
09:13AM	Do Wall Street Analysts Like DaVita Stock? (Barchart)
Aug-11-25 09:40AM	Are Investors Undervaluing DaVita (DVA) Right Now? (Zacks)
09:00AM	Maggie Anderson Joins JLL Partners as an Operating Partner (Business Wire)
Aug-07-25 07:00AM	Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights (GlobeNewswire)
Aug-06-25 01:20PM	Why DaVita (DVA) Stock Is Nosediving (StockStory) -9.04%
12:49PM	DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands (Zacks)
03:31AM	DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ... (GuruFocus.com)
Aug-05-25 10:54PM	Analyst Report: DaVita Inc. (Morningstar Research)
05:38PM	DaVita's (NYSE:DVA) Q2 Sales Beat Estimates (StockStory)
05:15PM	DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates (Zacks)
04:05PM	DaVita Inc. 2nd Quarter 2025 Results (PR Newswire)
04:19AM	Berkshire Hathaway Buys More Sirius XM Stock, Sells DaVita Shares in Recent Days (Barrons.com)
Aug-04-25 10:02PM	Berkshire Hathaway Buys More Sirius XM Stock, Sells Davita Shares in Recent Days (Barrons.com)
05:35PM	Encompass Health (EHC) Q2 Earnings and Revenues Surpass Estimates (Zacks)
08:00AM	Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization (GlobeNewswire)
Aug-03-25 11:05PM	DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Aug-01-25 10:31AM	Truist Reduces PT on DaVita Inc. (DVA) from $170 to $164; Zacks Keeps 'Hold' Rating (Insider Monkey)
Jul-31-25 06:00PM	DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
01:16PM	Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings? (Zacks)
08:37AM	OneOncology Names Ian Wong Chief Operating Officer (PR Newswire)
Jul-29-25 06:00PM	Chemed (CHE) Q2 Earnings Miss Estimates (Zacks)
10:00AM	DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-28-25 04:06PM	AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE (PR Newswire)
08:00AM	15 regions chosen for groundbreaking effort to reduce cardiovascular disease (NewMediaWire)
Jul-23-25 10:03AM	Ashley Snyder Joins Medical Home Network as Chief Development Officer to Lead Partnership Efforts (PR Newswire)
10:01AM	Universal Health to Report Q2 Earnings: What Do the Key Estimates Say? (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
12:06AM	3 Reasons to Avoid DVA and 1 Stock to Buy Instead (StockStory)
Jul-22-25 08:50AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
07:55AM	Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates (Zacks)
Jul-21-25 06:00PM	DaVita HealthCare (DVA) Stock Sinks As Market Gains: What You Should Know (Zacks)
12:10PM	Will DaVita HealthCare (DVA) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:35AM	HCA Healthcare to Report Q2 Earnings: Key Estimates to Note (Zacks)
Jul-17-25 05:37PM	DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call (PR Newswire)
Jul-16-25 03:51AM	DaVitas Quarterly Earnings Preview: What You Need to Know (Barchart)
Jul-15-25 06:00PM	DaVita HealthCare (DVA) Dips More Than Broader Market: What You Should Know (Zacks)
Jul-13-25 12:27AM	DaVita Reveals Its Developments Towards ESG Goals in Its Community Care Report (Insider Monkey)
Jul-10-25 09:50AM	Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock (Zacks)
Jul-09-25 06:15PM	DaVita HealthCare (DVA) Stock Sinks As Market Gains: Here's Why (Zacks)
Jul-03-25 08:37AM	Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, DaVita and The Pennant (Zacks)
Jul-02-25 10:10AM	4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space (Zacks)
09:40AM	Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term (Zacks)
Jul-01-25 06:15PM	DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts (Zacks)
Jun-24-25 08:19AM	FMS Stock Likely to Gain on New Optimization Plan FME Reignite (Zacks)
03:08AM	Is DaVita Stock Underperforming the S&P 500? (Barchart)
Jun-23-25 04:26PM	CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug (Investor's Business Daily)
Jun-19-25 06:01AM	Meet Middle Tennessee's Top Workplaces in 2025: Survey results are in (The Tennessean)
05:57AM	DaVita CEO Javier Rodriguez: The Trump administration is very aggressive in trying to change the trajectory of health care (Fortune)
Jun-17-25 08:56AM	Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs (The Wall Street Journal)
Jun-16-25 06:00PM	DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jun-11-25 11:34PM	Winners And Losers Of Q1: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks (StockStory)
11:30AM	DaVita HealthCare (DVA) Down 3.4% Since Last Earnings Report: Can It Rebound? (Zacks)

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BERKSHIRE HATHAWAY INC	10% Owner	Oct 27 '25	Sale	135.36	401,514	54,347,249	31,759,065	Oct 29 06:09 PM
BERKSHIRE HATHAWAY INC	10% Owner	Jul 31 '25	Sale	140.61	1,635,962	230,024,764	32,160,579	Aug 04 09:00 PM
HEARTY JAMES O	Chief Compliance Officer	Jul 23 '25	Sale	150.00	2,351	352,650	26,038	Jul 24 08:34 PM
HEARTY JAMES O	Officer	Jul 23 '25	Proposed Sale	150.00	2,351	352,650		Jul 23 04:05 PM
BERKSHIRE HATHAWAY INC	10% Owner	May 27 '25	Sale	139.45	103,274	14,401,483	33,796,541	May 27 09:34 PM
BERKSHIRE HATHAWAY INC	10% Owner	May 23 '25	Sale	137.81	64,066	8,828,933	33,899,815	May 27 09:34 PM
BERKSHIRE HATHAWAY INC	10% Owner	May 22 '25	Sale	138.98	32,660	4,538,983	33,963,881	May 27 09:34 PM
BERKSHIRE HATHAWAY INC	10% Owner	May 08 '25	Sale	147.11	1,145,938	168,576,647	33,996,541	May 12 04:05 PM
HEARTY JAMES O	Chief Compliance Officer	Mar 03 '25	Option Exercise	75.95	4,609	350,054	28,669	Mar 14 07:55 PM
BERKSHIRE HATHAWAY INC	10% Owner	Feb 14 '25	Sale	154.94	500,000	77,471,996	35,392,479	Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC	10% Owner	Feb 19 '25	Sale	154.09	129,938	20,022,517	35,142,479	Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC	10% Owner	Feb 18 '25	Sale	154.60	120,062	18,561,103	35,272,417	Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC	10% Owner	Feb 11 '25	Sale	156.01	203,091	31,684,430	35,892,479	Feb 13 07:50 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Nov 27 '24	Option Exercise	108.93	8,078	879,937	97,706	Nov 27 09:47 PM
Michael Staffieri	Officer	Nov 27 '24	Proposed Sale	167.09	7,902	1,320,345		Nov 27 03:29 PM
Michael Staffieri	Officer	Nov 18 '24	Proposed Sale	157.42	7,786	1,225,664		Nov 18 04:27 PM
Michael Staffieri	Officer	Nov 14 '24	Proposed Sale	155.94	7,459	1,163,167		Nov 14 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DVA

DaVita Inc

Upgrade your FINVIZ experience